Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
J Appl Clin Med Phys. 2022 Mar;23(3):e13518. doi: 10.1002/acm2.13518. Epub 2022 Jan 7.
Online magnetic resonance (MR)-guided radiotherapy is expected to benefit brain stereotactic radiosurgery (SRS) due to superior soft tissue contrast and capability of daily adaptive planning. The purpose of this study was to investigate daily adaptive plan quality with setup variations and to perform an end-to-end test for brain SRS with multiple metastases treated with a 1.5-Tesla MR-Linac (MRL). The RTsafe PseudoPatient Prime brain phantom was used with a delineation insert that includes two predefined structures mimicking gadolinium contrast-enhanced brain lesions. Daily adaptive plans were generated using six preset and six random setup variations. Two adaptive plans per daily MR image were generated using the adapt-to-position (ATP) and adapt-to-shape (ATS) workflows. An adaptive patient plan was generated on a diagnostic MR image with simulated translational and rotational daily setup variation and was compared with the reference plan. All adaptive plans were compared with the reference plan using the target coverage, Paddick conformity index, gradient index (GI), Brain V12 or V20, optimization time and total monitor units. Target doses were measured as an end-to-end test with two ionization chambers inserted into the phantom. With preset translational variations, V12 from the ATS plan was 17% lower than that of the ATP plan. With a larger daily setup variation, GI and V12 of the ATS plan were 10% and 16% lower than those of the ATP plan, respectively. Compared to the ATP plans, the plan quality index of the ATS plans was more consistent with the reference plan, and within 5% in both phantom and patient plans. The differences between the measured and planned target doses were within 1% for both treatment workflows. Treating brain SRS using an MRL is feasible and could achieve satisfactory dosimetric goals. Setup uncertainties could be accounted for using online plan adaptation. The ATS workflow achieved better dosimetric results than the ATP workflow at the cost of longer optimization time.
在线磁共振(MR)引导放射治疗有望使脑立体定向放射外科(SRS)受益,因为它具有更好的软组织对比度和每日自适应计划的能力。本研究旨在研究由于摆位变化引起的每日自适应计划质量,并对使用 1.5T MR-Linac(MRL)治疗多发性脑转移的 SRS 进行端到端测试。RTsafe PseudoPatient Prime 脑体模,配有一个包括两个预设结构的描绘插件,模仿钆增强的脑病变。使用六个预设和六个随机摆位变化生成每日自适应计划。使用自适应位置(ATP)和自适应形状(ATS)工作流程,为每天的每个 MR 图像生成两个自适应计划。在具有模拟平移和旋转每日摆位变化的诊断性 MR 图像上生成自适应患者计划,并与参考计划进行比较。使用目标覆盖率、Paddick 适形指数、梯度指数(GI)、脑 V12 或 V20、优化时间和总监测单位,将所有自适应计划与参考计划进行比较。使用插入体模的两个电离室对目标剂量进行端到端测试。对于预设的平移变化,ATS 计划的 V12 比 ATP 计划低 17%。对于较大的每日摆位变化,ATS 计划的 GI 和 V12 分别比 ATP 计划低 10%和 16%。与 ATP 计划相比,ATS 计划的计划质量指数与参考计划更一致,在体模和患者计划中均为 5%以内。两种治疗工作流程的测量与计划目标剂量之间的差异均在 1%以内。使用 MRL 治疗脑 SRS 是可行的,可以达到令人满意的剂量学目标。可以使用在线计划自适应来考虑摆位不确定性。ATS 工作流程比 ATP 工作流程在成本优化时间更长的情况下实现了更好的剂量学结果。